Computer-aided discovery of triazolothiadiazoles as DYRK1A-targeted neuroprotective agents

Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a promising target for drug discovery against neurological diseases. So far, no DYRK1A inhibitor has been approved for clinical use, partly due to...